title: [Medical treatment of migraine attacks in the child].
authors.affiliation: Service de neuropédiatrie, clinique de pédiatrie, hôpital Roger-Salengro, centre hospitalier régional et universitaire de Lille.
authors.forename: J C
authors.initials: JC
authors.lastname: Cuvellier
authors.forename: S
authors.initials: S
authors.lastname: Joriot
authors.forename: S
authors.initials: S
authors.lastname: Auvin
authors.forename: L
authors.initials: L
authors.lastname: Vallée
mesh_terms: D000082:Acetaminophen / Q000627:therapeutic use; D000367:Age Factors; D000700:Analgesics / Q000009:adverse effects / Q000627:therapeutic use*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D002648:Child; D004876:Ergot Alkaloids / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007052:Ibuprofen / Q000627:therapeutic use; D008019:Life Style; D008881:Migraine Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D023303:Oxazolidinones / Q000627:therapeutic use; D010290:Parents / Q000193:education; D010353:Patient Education as Topic; D010372:Pediatrics / Q000379:methods; D010880:Piperidines / Q000627:therapeutic use; D011759:Pyrrolidines / Q000627:therapeutic use; D012307:Risk Factors; D017366:Serotonin Receptor Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D018170:Sumatriptan / Q000627:therapeutic use; D013651:Taste Disorders / Q000139:chemically induced; D014230:Triazoles / Q000627:therapeutic use; D014363:Tryptamines / Q000627:therapeutic use; D014662:Vasoconstrictor Agents / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000700:Analgesics; D000894:Anti-Inflammatory Agents, Non-Steroidal; D004876:Ergot Alkaloids; D023303:Oxazolidinones; D010880:Piperidines; D011759:Pyrrolidines; D017366:Serotonin Receptor Agonists; D014230:Triazoles; D014363:Tryptamines; D014662:Vasoconstrictor Agents; C115647:eletriptan; C089750:zolmitriptan; D000082:Acetaminophen; C093622:rizatriptan; D018170:Sumatriptan; C106783:naratriptan; D007052:Ibuprofen